IE37102B1 - Composition - Google Patents

Composition

Info

Publication number
IE37102B1
IE37102B1 IE48/73A IE4873A IE37102B1 IE 37102 B1 IE37102 B1 IE 37102B1 IE 48/73 A IE48/73 A IE 48/73A IE 4873 A IE4873 A IE 4873A IE 37102 B1 IE37102 B1 IE 37102B1
Authority
IE
Ireland
Prior art keywords
sodium salt
range
carboxychromon
yloxy
microns
Prior art date
Application number
IE48/73A
Other languages
English (en)
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36763080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE37102(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of IE37102B1 publication Critical patent/IE37102B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE48/73A 1971-08-10 1973-01-12 Composition IE37102B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB3745671A GB1410588A (en) 1971-08-10 1971-08-10 Composition
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
ZA730284A ZA73284B (en) 1971-08-10 1973-01-15 Pharmaceutical powder composition containing sodium cromoglycate
AU51191/73A AU5119173A (en) 1971-08-10 1973-01-17 Composition
ES410910A ES410910A1 (es) 1971-08-10 1973-01-24 Un procedimiento para la preparacion de una composicion farmaceutica en polvo para inhalacion.

Publications (1)

Publication Number Publication Date
IE37102B1 true IE37102B1 (en) 1977-05-11

Family

ID=36763080

Family Applications (1)

Application Number Title Priority Date Filing Date
IE48/73A IE37102B1 (en) 1971-08-10 1973-01-12 Composition

Country Status (19)

Country Link
US (1) US4009280A (enExample)
JP (1) JPS5652001B2 (enExample)
AT (1) AT333974B (enExample)
AU (1) AU5119173A (enExample)
CA (1) CA992461A (enExample)
DE (1) DE2239091A1 (enExample)
DK (2) DK131891C (enExample)
ES (1) ES410910A1 (enExample)
FI (1) FI56487C (enExample)
FR (1) FR2150759B1 (enExample)
GB (1) GB1410588A (enExample)
IE (1) IE37102B1 (enExample)
IL (1) IL39990A (enExample)
LU (1) LU66875A1 (enExample)
NL (1) NL7210780A (enExample)
NO (1) NO140747C (enExample)
SE (1) SE411842B (enExample)
ZA (1) ZA73284B (enExample)
ZM (1) ZM11971A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5042827A (enExample) * 1973-08-20 1975-04-18
JPS5042819A (enExample) * 1973-08-20 1975-04-18
JPS5042826A (enExample) * 1973-08-20 1975-04-18
JPS6019043B2 (ja) * 1975-12-11 1985-05-14 ソニー株式会社 磁気再生装置
JPS5313111U (enExample) * 1976-07-16 1978-02-03
US4238502A (en) * 1978-08-03 1980-12-09 Fisons Limited Method of treating psychiatric conditions
BE891013A (fr) * 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
JP2003525842A (ja) † 1997-09-29 2003-09-02 インヘール セラピューティック システムズ， インコーポレイテッド 計量吸入器における使用のための安定化調製物
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6956021B1 (en) * 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
EP1210067A2 (en) * 1999-08-25 2002-06-05 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7871598B1 (en) * 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
WO2002009674A2 (en) * 2000-07-28 2002-02-07 Inhale Therapeutic Systems, Inc. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
WO2002053190A2 (en) 2000-12-29 2002-07-11 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
WO2002062317A2 (en) * 2001-02-06 2002-08-15 Innovata Biomed Limited Bimodal dry powder formulation for inhalation
WO2003043603A1 (en) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Particulate compositions for improving solubility of poorly soluble agents
US7182961B2 (en) * 2001-11-20 2007-02-27 Advanced Inhalation Research, Inc. Particulate compositions for pulmonary delivery
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US6889690B2 (en) * 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
TWI470107B (zh) * 2008-07-24 2015-01-21 Air Liquide 用於沉積含過渡金屬之膜的環戊二烯基過渡金屬前驅物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121096A (en) * 1961-12-27 1964-02-11 Roussel Uclaf New process of preparation of 3-methyl chromone
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
US3686412A (en) * 1965-03-25 1972-08-22 Colin Fitzmaurice Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190194A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-Phenoxy Compounds and Chromanone and Chromone Derivatives
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1223690A (en) * 1967-10-17 1971-03-03 Fisons Pharmaceuticals Ltd Substituted chromon-2-carboxylic acids
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
LU66875A1 (enExample) 1973-03-23
DK131891B (da) 1975-09-22
ZM11971A1 (en) 1973-02-21
US4009280A (en) 1977-02-22
DK146974B (da) 1984-03-05
AT333974B (de) 1976-12-27
NO140747C (no) 1979-11-07
DK131891C (da) 1976-02-23
NL7210780A (enExample) 1973-02-13
CA992461A (en) 1976-07-06
GB1410588A (en) 1975-10-22
NO140747B (no) 1979-07-30
DK535774A (enExample) 1975-06-02
IL39990A0 (en) 1972-09-28
FR2150759B1 (enExample) 1975-10-31
AU5119173A (en) 1974-07-18
ATA39073A (de) 1976-04-15
DE2239091A1 (de) 1973-02-22
ES410910A1 (es) 1976-07-16
FI56487B (fi) 1979-10-31
FR2150759A1 (enExample) 1973-04-13
ZA73284B (en) 1973-11-28
JPS5652001B2 (enExample) 1981-12-09
FI56487C (fi) 1980-02-11
SE411842B (sv) 1980-02-11
JPS4826764A (enExample) 1973-04-09
DK146974C (da) 1984-08-13
IL39990A (en) 1977-02-28

Similar Documents

Publication Publication Date Title
IE37102B1 (en) Composition
CA966842A (en) 2-hydrocarbyldithio-5-mercapto-1,3,4-thiadiazoles and their preparation
GB1448002A (en) Electrical connectors
GB1414678A (en) Dental creams
GB1263000A (en) 4,4',4''-trihydroxytriphenylmethylmethane and process for preparing it
CA937571A (en) Procede de preparation de l'eburnamonine
CA981942A (en) Wear resistant alloy and parts made therefrom
CA952062A (en) Technique for the preparation of ion implanted tantalum-aluminum alloy
CH557687A (fr) Mousqueton de securite, notamment pour la pratique de l'alpinisme.
GB1301555A (enExample)
CA923491A (en) Cardenolide-and bufadienolide-3-(2',3'-didesoxyglycosides) and process for their preparation
CA710830A (en) Disodium and calcium salt of the calcium complex of 2-aminocyclohexyl 2'-aminoethyl ether-n,n,n',n'-tetraacetic acid
CA993873A (fr) Derives du trimethyl-1,7,7 norbornane -2-spiro-2'-dioxolane-1',3', leur procede de preparation et leur application en therapeutique
CA959491A (en) Preparation of 2,4,6-tris-(hydroxybenzylthio) triazines
USD166932S (en) Base foe table lamps
GB1242212A (en) Drug for use in pharmaceutical composition
GB1366513A (en) Pharmaceutical compounds and compositions
USD138525S (en) Design for a toy vehicle
GB1214118A (en) Production of resorcinol
SCHULZ et al. Investigations on the liquidus and solidus curves of the copper-manganese and copper-nickel systems
CA927076A (en) Process for the manufacture of fine particulate maddrell's salt
CA993862A (fr) Composes intermediaires utilises dans la preparation de 11.alpha. - alcoxy estradiols
CA813888A (en) Dispositif et procede perfectionnes, utilisables notamment pour la preparation des peintures et des encres d'imprimerie
GB1243562A (en) Process for the production of coloured coatings
AU5724969A (en) Preparation of titanium phosphate crystals